Chelsea and Westminster Hospital, London, UK.
Oakfield Surgery, Newmarket, UK.
Post Reprod Health. 2020 Jun;26(2):101-109. doi: 10.1177/2053369120925193.
To describe the attitudes and perceptions of postmenopausal women from the United Kingdom regarding menopause, vulvo-vaginal atrophy and its therapeutic management.
Post hoc analysis of the United Kingdom population from the REVIVE-EU Study.
The survey contained questions about women's knowledge of menopause and vulvo-vaginal atrophy symptoms, impact on their life and sexual activities, communication with healthcare professionals and treatments.
The most frequent symptom of menopause was hot flushes (75%). Vulvo-vaginal atrophy symptoms had a significant impact on participants' ability to enjoy sexual intercourse (66%), spontaneity (62%) and ability to be intimate (61%); however, only 68% of women had been to their healthcare professional for advice. Half of the sample expected that doctors would initiate a discussion of menopausal symptoms and sexual health, but was in fact rare (5%). Only 27% were under current treatment without a clear therapy pattern, of which 43% used vaginal over-the-counter treatments, 28% prescription (Rx), and 13% both. Efficacy was the main limitation for over-the-counter treatments, while for Rx products were side effects and safety. Women highlighted the restoring of the natural condition of the vagina as the main goal for a treatment (35%). Many United Kingdom women did not feel the need to see any healthcare professional for their gynaecological symptoms. Overall satisfaction with treatment was only 44%.
Vulvo-vaginal atrophy remains underdiagnosed and undertreated in United Kingdom. There is a lack of coherent discussion about vulvo-vaginal atrophy symptoms with clinicians. Many United Kingdom healthcare professionals could improve proactive communication with patients about vulvo-vaginal atrophy.
描述英国绝经后妇女对绝经、外阴阴道萎缩及其治疗管理的态度和看法。
REVIVE-EU 研究英国人群的事后分析。
调查包含有关女性对绝经和外阴阴道萎缩症状的知识、对其生活和性生活的影响、与医疗保健专业人员的沟通和治疗等问题。
绝经最常见的症状是热潮红（75%）。外阴阴道萎缩症状对参与者享受性生活（66%）、自发性（62%）和亲密能力（61%）有显著影响；然而，只有 68%的女性曾因该问题向医疗保健专业人员寻求建议。一半的样本期望医生会主动讨论绝经症状和性健康问题，但实际上很少（5%）。只有 27%的女性正在接受治疗，但没有明确的治疗模式，其中 43%使用阴道非处方治疗，28%处方（Rx），13%两者兼有。非处方治疗的主要限制是疗效，而 Rx 产品的限制是副作用和安全性。女性强调治疗的主要目标是恢复阴道的自然状态（35%）。许多英国女性认为自己不需要因妇科症状看任何医疗保健专业人员。总体治疗满意度仅为 44%。
英国外阴阴道萎缩的诊断和治疗不足。临床医生缺乏对外阴阴道萎缩症状的一致讨论。许多英国医疗保健专业人员可以改善与患者就外阴阴道萎缩问题的主动沟通。
